Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 61, Issue 4, 2004, Pages 203-208

  Nava, Stefano ^a   Fuccella, L M ^b   Viglianti, B ^b  

^a IRCCS   (Italy)

^b Medical Department   (Italy)

Author keywords

COPD; Diaphragm; Malnutrition; Phosphorus

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON DIOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE; LOOP DIURETIC AGENT; METHYLXANTHINE DERIVATIVE; STEROID;

AGED; ARTICLE; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHRAGM; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DYSPNEA; ENERGY EXPENDITURE; FEMALE; HUMAN; INHALATION; LUNG CLEARANCE; LUNG FUNCTION; MALE; MALNUTRITION; NEUROMUSCULAR FUNCTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DRIVE; SNIFFING;

EID: 18044377959     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2004.682     Document Type: Article

References (26)

1. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
2. Fischer J, Magid N, Kallman C et al. Respiratory illness and hypophosphatemia. Chest 1983; 83: 504-508.
3. Fiaccadori E, Coffrini E, Ronda N et al. Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms and relationship with skeletal muscle phosphorous content. Chest 1990; 97: 857-868.
4. Fiaccadori E, Coffrini E, Fracchia C, Rampulla C, Montagna T, Borghetti A. Hyposphosphatemia and phosphorous depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD. Chest 1994; 105: 1392-1398.
5. Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med 1991; 324: 1445-1450.
6. Aubier M, Murciano D, Leconguic Y et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 315: 420-424.
7. Marchesani F, Valerio G, Dardes N, Viglianti B, Sanguinetti CM. Effect of intravenous fructose 1, 6-diphosphate administration in malnourished chronic obstructive pulmonary disease patients with chronic respiratory failure. Respiration 2000; 67: 177-182.
8. Vassilakopoulos T, Zakynthinos S, Roussos C. The tension-time index and the frequency/tidal volume ratio are the major pathophysiologic determinants of weaning failure and success. Am J Respir Crit Care Med 1998; 158: 378-85.
9. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Resp Dis 1991; 143: 905-911.
10. Pauwels R, Buist S, Calverley P, Jenkins C, Hurd S, on behalf of the Gold scientific committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
11. Baydur A, Behrakis PK, Zin WA, Jaeger MJ, Milic-Emili J. A simple method for assessing the validity of the oesophageal balloon technique. Am Rev Respir Dis 1982; 126: 788-791.
12. Mead J, Whittenberger JL. Physical properties of human lungs measured during spontaneous respiration. J Appl Physiol 1953; 5: 770-796.
13. Tobin M. Monitoring respiratory mechanics in spontaneously breathing patients; in Tobin MJ (ed): Principles and Practice of Intensive Care Monitoring. New York, McGraw-Hill, 1998, pp 617-654.
14. Appendini L, Patessio A, Zanaboni S et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 1069-1076.
15. Sassoon CS, Lodia R, Rheeman CH et al. Inspiratory muscle work of breathing during flow-by, demand-flow, and continuous-flow systems in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992 145: 1219-1222.
16. Jubran A, Tobin MJ. Pathophysiological basis of acute respiratory distress in patients who fail a trial of weaning from mechanical ventilation. Am J Respir Crit Care Med 1997; 155: 906-915.
17. Laroche CM, Carroll N, Moxham J, Green M. Clinical significance of severe isolated diaphragm weakness. Am Rev Respir Dis 1988; 138: 862-866.
18. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
19. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: 8-15.
20. Withelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol 1975; 23: 181-199.
21. McGavin CR, Gupta SP, McHardy GJR. Twelve minutes walking test for assessing disability in chronic bronchitis. BMJ 1976; 1: 822-823.
22. Appendini L, Purro A, Patessio A et al. Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 1996; 154: 1301-1309.
23. Hardin CD, Roberts TA. Metabolism of exogenously fructose 1, 6-biphosphate in hypoxic vascular smooth muscle. Am J Physiol 1994: 267: 2322-2325.
24. Juergens TM, Hardin CD. Fructose 1, 6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxia. Mol Cell Biochem. 1996; 154: 83-93.
25. Montanari A, Borghi L, Curti A et al. Skeletal muscle cell abnormalities in acute hypophoshatemia during total parenteral nutrition. Miner Electrolyte Metab 1984: 10: 52-57.
26. Galzigna L. Patogenesi della componente metabolica della fatica diaframmatica e considerazioni terapeutiche. Congress Digest 1998; 4: 1-8.